SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

P50750 (CDK9_HUMAN) Homo sapiens (Human)

Cyclin-dependent kinase 9 UniProtKBInterProSTRINGInteractive Modelling

372 aa; Sequence (Fasta) ; (Isoform 2); 13 identical sequences

Available Structures

28 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of HIV-1 Tat complexed with human P-TEFb Heteromer
O60563; P04608;
8-344
100.0ZN;
Crystal structure of HIV-1 Tat complexed with ATP-bound human P-TEFb Heteromer
O60563; P04608;
8-340
100.0ANP;MG;ZN;
Structure of full length CDK9 in complex with cyclinT and DRB Heteromer
O60563;
6-338
100.0
Crystal structure of HIV-1 Tat complexed with human P-TEFb and AFF4 Heteromer
O60563; P04608; Q9UHB7;
8-331
100.0YT3;SO4;ZN;
CDK9-Cyclin-T1 complex bound by compound 24 Heteromer
O60563;
5-328
97.45Q6E;TRS;PO4;
The AFF4 scaffold binds human P-TEFb adjacent to HIV Tat Heteromer
O60563; Q9UHB7;
8-330
100.0AMP;
crystal structure of P-TEFb complex with AFF4 and Tat Heteromer
O60563; P69698; Q9UHB7;
8-330
100.0ADN;ZN;
HIV-1 TAR loop in complex with Tat:AFF4:P-TEFb Heteromer
O60563; P04608; Q9UHB7;
8-330
100.0ZN;
CDK9/cyclin T1 in complex with KB-0742 Heteromer
O60563;
5-327
97.71VQE;
TAR complex with HIV-1 Tat-AFF4-P-TEFb Heteromer
O60563; P69697; Q9UHB7;
8-330
100.0ZN;
Structure of CDK9/cyclinT1 in complex with DRB Heteromer
O60563;
6-327
100.0PO4;GOL;RFZ;
Structure of CDK9/CyclinT in complex with S-CR8 Heteromer
O60563;
6-327
100.0SLQ;
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor Heteromer
O60563;
5-326
100.0T3E;
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor Heteromer
O60563;
7-327
100.0T7Z;GOL;
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor Heteromer
O60563;
6-326
99.67T6Q;
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor Heteromer
O60563;
7-327
100.0T3C;GOL;
Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor Heteromer
O60563;
6-326
100.0T9N;
CDK9/cyclin T in complex with CAN508 Heteromer
O60563;
8-328
100.0F18;
Crystal structure of full-length cdk9 in complex with cyclin t Heteromer
O60563;
7-327
100.0
Structure of CDK9/cyclin T1 in complex with inhibitor Heteromer
O60563;
6-326
99.67NJ6;
Crystal Structure of Human CDK9/cyclinT1 in complex with Flavopiridol Heteromer
O60563;
7-326
100.0PO4;CPB;
Crystal structure of CDK9-Cyclin T1 bound by compound 6 Heteromer
O60563;
7-326
100.0UT5;
Crystal Structure of Human CDK9/cyclinT1 in complex with MC180295 Heteromer
O60563;
7-326
100.0TO7;TOJ;PO4;
Crystal Structure of Human CDK9/cyclinT1 in Complex with ATP Heteromer
O60563;
7-325
100.0MG;ATP;TRS;
Crystal Structure of Human CDK9/cyclinT1 with A86 Heteromer
O60563;
8-326
100.0LCI;GOL;
structure of CDK9/cyclin T F241L Heteromer
O60563;
7-325
100.0
Crystal Structure of Human CDK9/cyclinT1 Heteromer
O60563;
8-325
100.0TRS;
CDK9/cyclin T in complex with CAN508 Heteromer
O60563;
8-325
100.0PO4;F18;GOL;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3mi9.1.Amonomer0.848-344
100.00

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24ec8.1.Amonomer0.82123-455
100.00